Literature DB >> 1739801

Prescribing in Europe--forces for change.

D Taylor1.   

Abstract

Mesh：

Year:  1992        PMID： 1739801      PMCID： PMC1881465          DOI： 10.1136/bmj.304.6821.239

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  International health spending: issues and trends.

Authors:  G J Schieber; J P Poullier
Journal:  Health Aff (Millwood)       Date:  1991       Impact factor: 6.301

2.  Limited lists of drugs: lessons from abroad.

Authors:  T Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1985-02-16

3.  Will the British Committee on Safety of Medicines be obsolete in 1993?

Authors:  J P Griffin
Journal:  J R Coll Physicians Lond       Date:  1991-01
  3 in total
  13 in total

1.  Consumption of antibiotics in Sweden, 1975 to 1992: pharmacoeconomic and clinical aspects.

Authors:  S R Norrby
Journal:  Pharmacoeconomics       Date:  1992-09       Impact factor: 4.981

2.  The influence of pharmacoeconomic factors on prescribing patterns in Ireland.

Authors:  J Feely
Journal:  Pharmacoeconomics       Date:  1992-08       Impact factor: 4.981

Review 3.  Drug utilisation review and pharmacoeconomics: interaction after parallel development?

Authors:  S Garattini; G Tognoni
Journal:  Pharmacoeconomics       Date:  1993-09       Impact factor: 4.981

Review 4.  Pharmacoeconomics of antibacterial treatment.

Authors:  P G Davey; M M Malek; S E Parker
Journal:  Pharmacoeconomics       Date:  1992-06       Impact factor: 4.981

5.  Health economics in primary care in the UK: containment of drug costs.

Authors:  T Walley; R T Edwards
Journal:  Pharmacoeconomics       Date:  1993-02       Impact factor: 4.981

6.  Impact of selective financing of drugs on pharmaceutical expenditure control in the province of Valladolid, Spain.

Authors:  M A de Marino; J M Marqués; A Velasco
Journal:  Pharmacoeconomics       Date:  1996-09       Impact factor: 4.981

7.  Can rational prescribing be summatively assessed?

Authors:  G Buckley; J Allen
Journal:  Occas Pap R Coll Gen Pract       Date:  1995-02

8.  Health protection and the European Community.

Authors:  M Joffe
Journal:  BMJ       Date:  1993-06-19

9.  Scenario analysis of the future of medicines.

Authors:  H Leufkens; F Haaijer-Ruskamp; A Bakker; G Dukes
Journal:  BMJ       Date:  1994-10-29

10.  Drug reimbursement: indicators of inappropriate resource allocation.

Authors:  Bernard Bégaud; Ulf Bergman; Hans-Georg Eichler; Hubert G M Leufkens; Peter J Meier
Journal:  Br J Clin Pharmacol       Date:  2002-11       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.